Match Document Document Title
8957240 Method for the purification of prostaglandins  
The present invention provides a method for the purification of a prostaglandin by supercritical fluid chromatography, said method comprising the use of a stationary phase and a mobile phase...
8846292 Radiation-sensitive composition  
A radiation-sensitive composition containing a resist compound having a high sensitivity, a high resolution, a high etching resistance, and a low outgas which forms a resist pattern with good...
8802147 Controlled release of biologically active compounds  
The present invention relates to biodegradable polymers (e.g., polyesters and polyester amides) derived from functionalized biologically active compounds that can provide site specific delivery of...
8765235 Polymerizable compound  
Provided is a novel polymerizable azomethine compound which has a high Δn and is colorless. The compound is represented by the formula (I). P1 and P2 each are a polymerizable group; m1 and m2 each...
8633332 Efficient isolation of cimiracemate A, and methods of use  
A method for isolating cimiracemate A from a Cimicifuga species is disclosed, comprising the steps of a) providing a sufficient quantity of raw materials from the Cimicifuga species, b) mixing the...
8628685 Mesogen-containing compounds  
Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of...
8623238 Mesogenic stabilizers  
The present invention relates to compounds represented by the following Formula Ic, in which R2-R6 can each independently be selected from hydrogen or hydrocarbyl (e.g., methyl); L1 and L4 are...
8614347 Fluorous dendrimers and methods for production thereof  
The present invention concerns the design of an environmentally friendly and efficient fluorous phase based on dendritic architectures containing short semifluorinated groups on their periphery.
8613868 Mesogenic stabilizers  
The present invention relates to compounds represented by the following Formula I, In Formula I, R1 and R2 are each independently selected from hydrogen, and optionally substituted hydrocarbyl,...
8592621 Precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease  
A description is given of precursor compounds of sweet taste receptor antagonists for the prevention or treatment of disease, in particular for the prevention or treatment of Type 2 diabetes. A...
8592622 Polymerizable fluorine-containing compound  
A polymerizable fluorine-containing compound represented by formula (1), wherein R1 represents a polymerizable double-bond containing group, R2 represents an acid-labile protecting group, R3...
8592131 Ortho-nitrobenzyl ester compound and positive type photosensitive resin composition including the same  
An ortho-nitrobenzyl ester compound including a compound represented by Chemical Formula 1, and a positive photosensitive resin composition including the same are provided.
8586607 Compounds for the treatment of metabolic diseases  
There is provided novel compounds capable of modulating the G-protein-coupled receptor GPR40, compositions comprising the compounds, and methods for their use for controlling insulin levels in...
8580775 Use of derivatives of sinapinic acid and compositions comprising such derivatives  
The present invention relates to substances which can be used as cosmetic ingredients, especially for skin whitening and as cosmetic agents against signs of ageing skin. The present invention also...
8541157 Resist composition, method of forming resist pattern, compound and acid generator including the same  
A resist composition including a base component (A) which exhibits changed solubility in an alkali developing solution under the action of acid and an acid-generator component (B) which generates...
8519178 Method for the purification of prostaglandins  
The present invention provides a method for the purification of a prostaglandin by supercritical fluid chromatography, said method comprising the use of a stationary phase and a mobile phase...
8501037 Optically anisotropic compound and resin composition comprising the same  
Disclosed is a compound having high optical anisotropy and high compatibility with a polymer resin, which is represented by Formula 1 and has at least one substituent introduced to a biphenyl...
8487125 Method for producing caffeic acid phenyl ester and its analogues  
A method for producing caffeic acid phenyl ester and its analogues, which includes the steps of: (i) reacting, in a solvent, a salt of a compound of formula (II) with an organic halide having the...
8481519 Isolation of atraric acid, synthesis of atraric acid derivatives, and use of atraric acid and the derivatives thereof for the treatment of benign prostatic hyperplasia, prostate carcinoma and spinobulbar muscular atrophy  
A method for isolating atraric acid from biological material, atraric acid derivatives, the chemical synthesis thereof, and the use of atraric acid and the derivatives thereof for treating or...
8431039 Mesogenic stabilizers  
The present invention relates to compounds represented by the following Formula Ia, in which each R1-R6 can in each case be independently selected from hydrogen or hydrocarbyl (e.g., methyl); R7...
8399696 Functionalized biodegradable triclosan monomers and oligomers for controlled release  
This invention relates to the discovery of functionalized triclosan monomers and oligomers that, when incorporated into a substrate of, or applied as part of a coating to, medical devices and/or...
8349210 Mesogenic stabilizers  
The present invention relates to compounds represented by the following Formula I, in which R1-R6 can each independently be selected from hydrogen or hydrocarbyl (e.g., methyl); L1 is a divalent...
8293134 Optically anisotropic material, optical element and optical information writing/reading device  
An optically anisotropic material having a good durability against light is provided. Further, an optical element having a good durability against light and an optical information writing/reading...
8278332 Photostabilization of retinoids with alkoxycrylene compounds  
The photostabilizing electronic excited state energy—particularly singlet state energy from retinoid compounds—has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate...
8263051 Photostabilization of resveratrol with alkoxycrylene compounds  
The photostabilizing electronic excited state energy—particularly singlet state energy from resveratrol compounds—has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate...
8257903 Compound, positive resist composition and method for formation of resist pattern  
The present invention provides a compound that can be used within a resist composition, an intermediate compound for the compound, a positive resist composition, and a method for forming a resist...
8232422 Functionalized biodegradable triclosan monomers and oligomers for controlled release  
This invention relates to the discovery of functionalized triclosan monomers and oligomers that, when incorporated into a substrate of, or applied as part of a coating to, medical devices and/or...
8173685 Pleuromutilin derivatives and their use as antimicrobials  
A compound of formula (I) or of formula (II) wherein X is oxygen or sulfur, and Y is a residue of pipecolic acid or a residue of an amino acid, preferably a naturally occurring amino acid.
8133477 Dispersions of inorganic particulates containing alkoxycrylene  
A composition comprising an inorganic particulate material in an amount of about 20 wt % to about 70 wt %, a carrier for the particulate material comprising a compound of formula (I) in an amount...
8129561 Processes for intermediates for macrocyclic compounds  
The present invention is directed to novel macrocyclic compounds of formula (I) and their pharmaceutically acceptable salts, hydrates or solvates: wherein R1, R2, R3, R4, R5, R6, n1, m, p Z1, Z2,...
8101095 Antiferroelectric orthoconic liquid crystalline material with long pitch and the method of its preparation  
The racemic and chiral compounds expressed by common formula 1 and formula 2: wherein the lateral substituents X1, X2, X3, X4, X5, X6, X7 and X8 in the benzene rings represent independently...
8070989 Photostabilization of retinoids with alkoxycrylene compounds  
The photostabilizing electronic excited state energy—particularly singlet state energy from retinoid compounds—has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate...
8053591 Functionalized biodegradable triclosan monomers and oligomers for controlled release  
This invention relates to the discovery of functionalized triclosan monomers and oligomers that, when incorporated into a substrate of, or applied as part of a coating to, medical devices and/or...
8043789 Photosensitive compound and photoresist composition including the same  
A photosensitive compound whose size is smaller than conventional polymer for photoresist, and which has well-defined (uniform) structure, and a photoresist composition including the same are...
7988884 Preparation of sterically hindered hydroxyphenylcarboxylic acid esters  
A novel manufacturing process is described for producing hindered phenolic alkyl esters, which may be useful as antioxidants. This process simplifies catalyst neutralization and removal during the...
7923573 Benzene compound having 2 or more substituents  
A superior LXR modulator is provided. A compound represented by the general formula (I): [wherein R1: —COR9 (wherein R9: alkyl, optionally substituted alkoxy or optionally substituted amino); R2:...
7910019 Mesogen containing compounds  
Compounds including at least one mesogenic substructure and at least one long flexible segment and methods of synthesizing the same are disclosed. Formulations which include various embodiments of...
7718656 Prostaglandin derivatives  
Nitroderivatives of prostaglandin amides having improved pharmacological activity and enhanced tolerability are described. They can be employed for the treatment of glaucoma and ocular hypertension.
7642370 Method for preparing prostaglandin derivative  
A method for preparing a prostaglandin derivative represented by the following general formula (I): (wherein Ph represents phenyl group, R1 represents a C1-7 alkyl group, a C1-7 alkenyl group,...
7618690 Polymerizable liquid crystal compound, liquid crystal composition, optical anisotropic material and optical element  
A liquid crystal compound represented by the formula CH2═CR1—COO-(L)k-E1-E2-E3-E4-R2 wherein R1: a hydrogen atom or a methyl group; R2: a C1-8 alkyl group; k: 0 or 1; L: —(CH2)pO— or —(CH2)q—...
7569518 Pyridazine Compound and Use Thereof  
A pyridazine compound represented by formula (1): has an excellent plant disease controlling effect.
7538242 Optically active PPAR-activating compound intermediate and method for producing same  
The present invention provides a production intermediate for compound (A-1) and a method for producing the intermediate at high yield and high optical yield.
7528271 Intermediates, process for their preparation and synthesis of 1,4-benzoquiones  
The present invention discloses a new process for the preparation of 1,4-benzoquiones of formula (II) wherein R1, R2, R3 and R4 are independently selected from the group consisting of branched or...
7442418 Polymerizable liquid crystal compound, liquid crystal composition, optical anisotropic material and optical element  
The present compound represented by formula(I) CH2═CR1—COO—(L)k-E1-E2-E3-(E4)m-(E5)n-R2 (1) provided that the symbols in the formula have the following meanings: R1: a hydrogen atom or a methyl...
7396953 Angiogenesis inhibitors and pharmaceutical/cosmetic applications thereof  
Novel derivatives of fumagalone have the general formula (I): and are useful angiogenes is inhibitors; these can be formulated into pharmaceutical compositions suited for human or veterinary...
7396954 Intermediates in producing phenoxyacetic acid preventives and method of using the same  
The present invention provides novel intermediates represented by general formula (I) etc. for preparing a phenoxyacetic acid derivative represented by general formula (X) or a pharmaceutically...
7371888 α-(Trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents  
Compounds having a formula: or a pharmaceutically acceptable salt or prodrug thereof, are provided, and are useful for the treatment of metabolic disorders.
7358383 Polyphenol proteasome inhibitors, synthesis, and methods of use  
The present invention relates to synthetic green tea derived polyphenolic compounds, their modes of syntheses, and their use in inhibiting proteasomal activity and in treating cancers. The present...
7282596 Method and intermediate for preparing a prostaglandin F-type compound  
A method for preparing a prostaglandin F-type compound. Also disclosed is an intermediate of the following formula (II) compound wherein R′, X and A have the same meaning as given in the...
7279593 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders  
This invention relates to novel compounds which are thyroid receptor ligands, preferably antagonists, and to methods for using such compounds in the treatment of cardiac and metabolic disorders,...